149 related articles for article (PubMed ID: 6095666)
1. Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Am J Obstet Gynecol; 1984 Dec; 150(8):924-7. PubMed ID: 6095666
[TBL] [Abstract][Full Text] [Related]
2. Oral etoposide in gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Cancer Treat Rep; 1984 May; 68(5):775-7. PubMed ID: 6327035
[TBL] [Abstract][Full Text] [Related]
3. Primary oral etoposide therapy in gestational trophoblastic disease. An update.
Wong LC; Choo YC; Ma HK
Cancer; 1986 Jul; 58(1):14-7. PubMed ID: 3011237
[TBL] [Abstract][Full Text] [Related]
4. Ovarian dysfunction in patients with gestational trophoblastic neoplasia treated with short intensive courses of etoposide (VP-16-213).
Choo YC; Chan SY; Wong LC; Ma HK
Cancer; 1985 May; 55(10):2348-52. PubMed ID: 2985232
[TBL] [Abstract][Full Text] [Related]
5. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
6. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
Kohorn EI
J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of etoposide in gestochoriocarcinoma.
D'Incalci M; Sessa C; Rossi C; Roviaro G; Mangioni C
Cancer Treat Rep; 1985 Jan; 69(1):69-72. PubMed ID: 2981622
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma.
Newlands ES; Bagshawe KD
Eur J Cancer (1965); 1980 Mar; 16(3):401-5. PubMed ID: 6154579
[No Abstract] [Full Text] [Related]
9. Single agent etoposide in gestational trophoblastic tumours. Experience at Charing Cross Hospital 1978-1987.
Hitchins RN; Holden L; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1041-6. PubMed ID: 2842160
[TBL] [Abstract][Full Text] [Related]
10. Etoposide.
N Engl J Med; 1985 Aug; 313(8):518-9. PubMed ID: 2991763
[No Abstract] [Full Text] [Related]
11. Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate.
Barter JF; Soong SJ; Hatch KD; Orr JW; Partridge EC; Austin JM; Shingleton HM
Gynecol Oncol; 1989 Apr; 33(1):82-4. PubMed ID: 2467846
[TBL] [Abstract][Full Text] [Related]
12. New chemotherapeutic agents in the management of gestational trophoblastic disease.
Newlands ES
Semin Oncol; 1982 Jun; 9(2):239-43. PubMed ID: 6289468
[No Abstract] [Full Text] [Related]
13. Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide.
Theodore C; Azab M; Droz JP; Assouline A; George M; Piot G; Bellet D; Michel G; Amiel JL
Cancer; 1989 Nov; 64(9):1824-8. PubMed ID: 2551474
[TBL] [Abstract][Full Text] [Related]
14. Fertility in patients with gestational trophoblastic tumors treated with etoposide.
Adewole LF; Rustin GJ; Newlands ES; Dent J; Bagshawe KD
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1479-82. PubMed ID: 3036533
[TBL] [Abstract][Full Text] [Related]
15. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
16. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
Matsui H; Iitsuka Y; Seki K; Sekiya S
Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
[TBL] [Abstract][Full Text] [Related]
17. The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment.
Bidziñski M; Lemieszczuk B; Drabik M
Eur J Gynaecol Oncol; 1997; 18(6):541-3. PubMed ID: 9443032
[TBL] [Abstract][Full Text] [Related]
18. Medroxyprogesterone acetate in non-metastatic gestational trophoblastic disease.
Goldberg GL; Cloete K; Bloch B; Wiswedel K; Altaras MM
Br J Obstet Gynaecol; 1987 Jan; 94(1):22-5. PubMed ID: 2434125
[TBL] [Abstract][Full Text] [Related]
19. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
20. [Phase II study of etoposide (NK 171) in trophoblastic disease. Study Group on Etoposide (NK 171) for Trophoblastic Disease].
Takeuchi S; Kanazawa K; Ichinoe K; Takamizawa H; Ishige H; Soma H; Akiya K; Hachiya S; Kawashima Y; Maeda M
Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1266-76. PubMed ID: 3023504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
